Effect of Chemotherapy on Health-Related Quality of Life among Early-Stage Ovarian Cancer Survivors: A Study from the Population-Based Profiles Registry
Author(s) -
Celine Bhugwandass,
Johanna M.A. Pijnenborg,
Brenda Pijlman,
Nicole P. M. Ezendam
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.3243
Subject(s) - medicine , stage (stratigraphy) , ovarian cancer , quality of life (healthcare) , cancer registry , cancer , chemotherapy , population , oncology , adjuvant , adjuvant chemotherapy , breast cancer , paleontology , nursing , environmental health , biology
There is wide variation in the application of adjuvant chemotherapy in early-stage epithelial ovarian cancer. Our aim was to assess differences in health-related quality of life (hrqol) between patients with early-stage ovarian cancer who did or did not receive chemotherapy as adjuvant treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom